Summary
The product Anandromed 50, manufactured by Deus Medical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number DM22837, was submitted by the reseller DEUSPOWER.SHOP and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Oxymetholone, with measured concentrations of 52.51 mg in the first pill and 52.78 mg in the second pill, slightly exceeding the labeled claim of 50 mg per pill.
The testing process began on 18 November 2020, with the sample received the same day and analysis completed on 21 November 2020. While the results confirm accurate dosing, scrutiny of reseller-submitted samples is essential to ensure reliability. Resellers may select specific batches that meet high-quality standards, raising questions about product consistency across the broader market. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Deus Medical
- Product Name: Anandromed 50
- Active Ingredient: Oxymetholone
- Batch Number: DM22837
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #09165
- Testing Ordered: 18 November 2020
- Sample Received: 18 November 2020
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: DEUSPOWER.SHOP (Reseller)
- Analysis Paid For By: DEUSPOWER.SHOP
Testing Results
- Specification: 50 mg per pill (as stated on the label)
- Measured Concentration:
- First Pill: 52.51 mg
- Second Pill: 52.78 mg
- Accuracy: Slightly above the labeled claim
Verification Details
- Verification URL: https://janoshik.com/tests/09165_5HEHDRXHHCCD
Evaluation of Reseller-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission and funding by the reseller DEUSPOWER.SHOP. Resellers often select optimal batches for testing, which may not fully represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Anandromed 50 (Oxymetholone 50 mg/pill) is slightly overdosed, with measured concentrations of 52.51 mg and 52.78 mg. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
